Literature DB >> 1372293

Stable, conserved outer membrane epitope of strains of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever.

A J Lesse1, L L Gheesling, W E Bittner, S D Myers, G M Carlone.   

Abstract

Brazilian purpuric fever is a rapidly fatal childhood disease associated with a clonal strain of Haemophilus influenzae biogroup aegyptius. We describe a conserved, surface-exposed epitope present on 95% of H. influenzae biogroup aegyptius isolates that are associated with Brazilian purpuric fever. This epitope, defined by reaction with the monoclonal antibody 8G3, is on or associated with the 48-kDa heat-modifiable P1 protein. The epitope is absent on strains of H. influenzae biogroup aegyptius that are not associated with Brazilian purpuric fever but is present on one strain of H. influenzae biotype II. None of 81 other Haemophilus strains tested reacted with 8G3. The sensitivity and specificity of the 8G3 monoclonal antibody in detecting Brazilian case-clone strains of H. influenzae biogroup aegyptius associated with Brazilian purpuric fever are 95 and 99%, respectively. Immunoelectron microscopy revealed that the epitope is surface exposed, and N-terminal amino acid sequencing of an 8G3-reactive P1 protein from a strain of H. influenzae biogroup aegyptius showed 100% correlation with the published N-terminal amino acid sequence of a P1 protein of H. influenzae type b. The virulence of the organism in an infant rat model of bacteremia was not dependent on the expression of this epitope.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372293      PMCID: PMC257003          DOI: 10.1128/iai.60.4.1351-1357.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody.

Authors:  T F Murphy; L C Bartos; P A Rice; M B Nelson; K C Dudas; M A Apicella
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

2.  PBP profiles of Haemophilus influenzae, H. aegyptius, and the H. influenzae biogroup aegyptius associated with Brazilian Purpuric Fever.

Authors:  P M Mendelman; D O Chaffin
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Sep-Oct       Impact factor: 2.803

3.  Brazilian purpuric fever in Western Australia.

Authors:  B E Wild; J W Pearman; P B Campbell; P K Swan; D L Garry
Journal:  Med J Aust       Date:  1989-03-20       Impact factor: 7.738

4.  Potential virulence factors of Haemophilus influenzae biogroup aegyptius in Brazilian purpuric fever. The Brazilian Purpuric Fever Study Group.

Authors:  G M Carlone; L Gorelkin; L L Gheesling; S K Hoiseth; M H Mulks; S P O'Connor; R S Weyant; J E Myrick; L W Mayer; R J Arko
Journal:  Pediatr Infect Dis J       Date:  1989-04       Impact factor: 2.129

5.  Purification, cloning, and sequence of outer membrane protein P1 of Haemophilus influenzae type b.

Authors:  R Munson; S Grass
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  Resistance to serum bactericidal activity distinguishes Brazilian purpuric fever (BPF) case strains of Haemophilus influenzae biogroup aegyptius (H. aegyptius) from non-BPF strains. Brazilian Purpuric Fever Study Group.

Authors:  M H Porto; G J Noel; P J Edelson
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

7.  Expression of the heat-modifiable major outer membrane protein of Haemophilus influenzae type b is unrelated to virulence.

Authors:  M S Hanson; L D Cope; E J Hansen
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

8.  rRNA gene restriction patterns of Haemophilus influenzae biogroup aegyptius strains associated with Brazilian purpuric fever.

Authors:  K Irino; F Grimont; I Casin; P A Grimont
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

Review 9.  Potential virulence-associated factors in Brazilian purpuric fever. Brazilian Purpuric Fever Study Group.

Authors:  G M Carlone; L Gorelkin; L L Gheesling; A L Erwin; S K Hoiseth; M H Mulks; S P O'Connor; R S Weyant; J Myrick; L Rubin
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

Review 10.  Microbiology of Brazilian purpuric fever and diagnostic tests. Brazilian Purpuric Fever Study Group.

Authors:  B Swaminathan; L W Mayer; W F Bibb; G W Ajello; K Irino; K A Birkness; C F Garon; M W Reeves; M C de Cunto Brandileone; F O Sottnek
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

View more
  3 in total

1.  DNA sequence analysis and restriction fragment length polymorphisms of the P1 gene of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever.

Authors:  R B Reed; J B Frost; K Kort; S D Myers; A J Lesse
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

2.  The Microbial Rosetta Stone Database: a compilation of global and emerging infectious microorganisms and bioterrorist threat agents.

Authors:  David J Ecker; Rangarajan Sampath; Paul Willett; Jacqueline R Wyatt; Vivek Samant; Christian Massire; Thomas A Hall; Kumar Hari; John A McNeil; Cornelia Büchen-Osmond; Bruce Budowle
Journal:  BMC Microbiol       Date:  2005-04-25       Impact factor: 3.605

3.  Human microvascular endothelial tissue culture cell model for studying pathogenesis of Brazilian purpuric fever.

Authors:  F D Quinn; R S Weyant; M J Worley; E H White; E A Utt; E A Ades
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.